Dividend King Abbott Shows Why 52 Consecutive Increases Weren't Luck With Strong Cash Flow Coverage

Core Viewpoint - Abbott Laboratories (NYSE: ABT) is recognized not only for its dividend payments but also for its broader financial strategies and growth potential [1] Group 1: Financial Performance - The company has demonstrated consistent revenue growth, indicating strong operational performance [1] - Abbott's dividend yield is competitive, appealing to income-focused investors [1] Group 2: Market Position - Abbott Laboratories holds a significant position in the healthcare sector, leveraging its diverse product portfolio [1] - The company is well-regarded for its innovation in medical devices and diagnostics, contributing to its market strength [1]